Sign up to save your podcasts
Or
Share Innovative Therapeutics: How Pathophysiology Guides New AAD Treatment Development
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Innovative Therapeutics: How Pathophysiology Guides New AAD Treatment Development
CME credits: 1.25
Valid until: 15-10-2025
Claim your CME credit at https://reachmd.com/programs/cme/innovative-therapeutics-how-pathophysiology-guides-new-aad-treatment-development/27100/
This series of bite-sized episodes contains important information on diagnosing and treating agitation in Alzheimer’s disease (AAD). Drs. Anton Porsteinsson and Brendan Montano discuss best practices for recognizing early symptoms, diagnosing patients, and treating their AAD.
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 1.25
Valid until: 15-10-2025
Claim your CME credit at https://reachmd.com/programs/cme/innovative-therapeutics-how-pathophysiology-guides-new-aad-treatment-development/27100/
This series of bite-sized episodes contains important information on diagnosing and treating agitation in Alzheimer’s disease (AAD). Drs. Anton Porsteinsson and Brendan Montano discuss best practices for recognizing early symptoms, diagnosing patients, and treating their AAD.